Skip to main content

Diagnostic options · UAE

Neuromuscular Genetic tests in Dubai & UAE

Compare available Neuromuscular Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

11

Listed price range

1,700.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neuromuscular Genetic test prices

Showing 1–11 of 11 matching tests.

Neuromuscular Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5205
CHRNB1 Gene Congenital Myasthenic Syndrome Genetic Test

This test analyzes the CHRNB1 gene to detect mutations associated with Congenital Myasthenic Syndrome (CMS). It identifies single-nucleotide variants (SNVs) and small insertions or...

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CHRNB1 gene", "Single-nucleotide variants (SNVs)", "Small insertions or deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required.", "Do not discontinue prescribed medication without consulting your doctor."]
Indications
["Suspected Congenital Myasthenic Syndrome (CMS)", "Clinical presentation strongly pointing to CHRNB1 involvement"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101399-0 ICD-10: G70.0
Clinical summary
This test analyzes the CHRNB1 gene to detect mutations associated with Congenital Myasthenic Syndrome (CMS). It identifies single-nucleotide variants (SNVs) and small insertions or deletions (indels) within the gene.
TEST-3953
COL6A1 Gene Bethlem Myopathy Next‑Generation Sequencing (Genetic Test

This test identifies genetic variants in the COL6A1 gene associated with Bethlem myopathy.

Whole Blood, Extracted DNA, or FTA Card 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL6A1 gene variants", "SNVs", "Indels", "CNVs"]
Parameters
[]
Preparation
["Full disclosure of all medications, supplements, and clinical history before testing is essential."]
Indications
["Suspected Bethlem myopathy", "Family history of Bethlem myopathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101385-9 ICD-10: G71.0
Clinical summary
This test identifies genetic variants in the COL6A1 gene associated with Bethlem myopathy.
TEST-3921
COL6A2 Gene NGS Test for Bethlem Myopathy

This test evaluates the COL6A2 gene for pathogenic variants associated with Bethlem myopathy.

Peripheral whole blood (3–5 mL EDTA) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL6A2 gene", "Deletions/Duplications in the COL6A2 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected Bethlem myopathy", "Family history of collagen VI-related muscular dystrophy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48813-3 ICD-10: G71.0
Clinical summary
This test evaluates the COL6A2 gene for pathogenic variants associated with Bethlem myopathy.
TEST-5256
DMD Gene Duchenne Muscular Dystrophy Genetic Test

This genetic test evaluates the DMD gene for mutations associated with Duchenne Muscular Dystrophy.

Whole blood in EDTA, extracted DNA, or dried blood spot on FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DMD gene deletions", "DMD gene duplications", "DMD gene point mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions or bone marrow transplants"]
Indications
["Suspected Duchenne Muscular Dystrophy", "Family history of DMD/BMD", "Elevated CPK levels with muscle weakness", "Carrier screening for females"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51938-5 ICD-10: G71.0
Clinical summary
This genetic test evaluates the DMD gene for mutations associated with Duchenne Muscular Dystrophy.
TEST-5130
DYSF Gene (Miyoshi Myopathy) Genetic Test

This test analyzes the DYSF gene for mutations associated with Miyoshi myopathy and related muscle disorders.

Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DYSF gene", "Exon and intron coverage of the DYSF gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any bleeding disorders"]
Indications
["Suspected Miyoshi myopathy", "Family history of dysferlinopathy", "Differential diagnosis of muscular dystrophies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94805-5 ICD-10: G71.0
Clinical summary
This test analyzes the DYSF gene for mutations associated with Miyoshi myopathy and related muscle disorders.
TEST-5245
LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test

This genetic test evaluates the LAMA2 gene for pathogenic variants associated with merosin-deficient congenital muscular dystrophy type 1A.

Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["LAMA2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected diagnosis of merosin-deficient congenital muscular dystrophy (MDC1A)", "Carrier screening for individuals with a family history of MDC1A", "Familial risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93590-0 ICD-10: G71.0
Clinical summary
This genetic test evaluates the LAMA2 gene for pathogenic variants associated with merosin-deficient congenital muscular dystrophy type 1A.
TEST-429
Limb-Girdle Muscular Dystrophy (LGMD) Comprehensive Genetic Panel Test

This test identifies pathogenic genetic variants in multiple genes associated with Limb-Girdle Muscular Dystrophy (LGMD). It uses Next-Generation Sequencing (NGS) and Multiplex Lig...

Peripheral Whole Blood 14–21 Working Days 1,700.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in over 30 LGMD-associated genes", "Point mutations", "Copy number variants (deletions/duplications)"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications unless advised otherwise by your physician"]
Indications
["Suspected diagnosis of Limb-Girdle Muscular Dystrophy", "Family history of LGMD", "Genetic counseling for individuals with muscle weakness"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69047-9 ICD-10: G71.09
Clinical summary
This test identifies pathogenic genetic variants in multiple genes associated with Limb-Girdle Muscular Dystrophy (LGMD). It uses Next-Generation Sequencing (NGS) and Multiplex Ligation-dependent Probe Amplification (MLPA) to detect mutations.
TEST-5340
MYH7 Distal Myopathy Type 1 (Laing Distal Myopathy) Gene Sequencing Test

This test analyzes the MYH7 gene for pathogenic variants associated with early-onset distal muscle weakness.

Peripheral whole blood (3–5 mL in EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MYH7 gene coding region", "Copy Number Variations (CNVs) in MYH7"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Diagnosis of suspected MYH7 Distal Myopathy Type 1", "Confirmation of diagnosis in individuals with clinical features", "Genetic counselling for at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94218-4 ICD-10: G71.0
Clinical summary
This test analyzes the MYH7 gene for pathogenic variants associated with early-onset distal muscle weakness.
TEST-5166
PABPN1 Gene Oculopharyngeal Muscular Dystrophy (OPMD) Genetic Test

This test detects GCG trinucleotide repeat expansions in the PABPN1 gene, the cause of oculopharyngeal muscular dystrophy.

Peripheral Whole Blood or Buccal Swab (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GCG trinucleotide repeat size in the PABPN1 gene", "Mosaicism", "Large deletions/duplications"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusion (within 3 months)"]
Indications
["Suspected Oculopharyngeal Muscular Dystrophy (OPMD)", "Family history of OPMD", "Diagnostic confirmation", "Predictive testing", "Carrier status analysis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94772-6 ICD-10: G71.0
Clinical summary
This test detects GCG trinucleotide repeat expansions in the PABPN1 gene, the cause of oculopharyngeal muscular dystrophy.
TEST-4392
PLEC Gene Epidermolysis Bullosa Simplex with Muscular Dystrophy Genetic Test

This genetic test analyzes the PLEC gene for mutations associated with Epidermolysis Bullosa Simplex with Muscular Dystrophy.

Peripheral Whole Blood or DNA FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PLEC gene pathogenic variants", "Point mutations", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["Fasting is not required", "Attend genetic counselling session prior to sample collection", "Avoid discontinuing prescribed medications without physician approval", "Provide detailed personal and family medical history"]
Indications
["Suspected Epidermolysis Bullosa Simplex with Muscular Dystrophy", "Family history of the disorder", "Need for genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q81.0, G71.0
Clinical summary
This genetic test analyzes the PLEC gene for mutations associated with Epidermolysis Bullosa Simplex with Muscular Dystrophy.
TEST-5290
TPM3 Gene Nemaline Myopathy Type 1 Genetic Test

This genetic test analyzes the TPM3 gene for mutations associated with Nemaline Myopathy Type 1.

Whole blood, extracted DNA, or FTA card (peripheral blood) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TPM3 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling", "Submission of a three-generation pedigree chart", "Do not discontinue prescribed medication without consulting your physician"]
Indications
["Suspected Nemaline Myopathy Type 1", "Family history of Nemaline Myopathy Type 1", "Congenital muscle weakness"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94400-5 ICD-10: G71.2
Clinical summary
This genetic test analyzes the TPM3 gene for mutations associated with Nemaline Myopathy Type 1.

Category overview

Neuromuscular Genetic: overview

When clinical signs strongly point to a specific neuromuscular breakdown, getting a targeted genetic confirmation is the key to unlocking the safest, most effective long-term management and reproductive confidence. As a highly focused diagnostic tool in our Molecular Genetics services, Neuromuscular Genetic testing specifically targets the exact DNA mutations responsible for your family's unique presentation. By leveraging advanced sequencing and deletion/duplication analysis, this precise genomic screening provides the definitive data necessary to assess disease severity, evaluate carrier risks for future children, and safely guide customized pediatric and adult neurology care. Consistently trusted by neurologists across the top diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and incredibly efficient reporting. Protect your family's mobility—schedule your neuromuscular genetic testing in UAE, coordinate a comfortable home sample collection, or connect with our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.